Page results
-
Introduction of Bordetella pertussis PCR testing at Halo laboratory (Health Services Laboratories)
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Dr. Patrick Murphy is a principal clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
The video-assisted stroke triage project, developed by the UCLH stroke service in partnership London Ambulance Service (LAS) has won the HSJ Patient Safety Award for Clinical Governance & Risk Management in Patient Safety.
File results
-
FOI/2022/0328 - Treatment for migraine
-
FOI/2022/0330 - Sleep and respiratory services
-
FOI/2022/0333 - Maternity care report
-
FOI/2022/0338 - X-ray reporting and interpretation of nasogastric tube placement
-
FOI/2022/0344 - Patient Administration System (PAS) used at Trust
-
FOI/2022/0345 - Contact details for Director of Estates and Facilities
-
FOI/2022/0346 - Renal cell carcinoma and melanoma treatments
-
FOI/2022/0347 - Annual data of service users who received IVF treatment
-
FOI/2022/0352 - Electronic Patient Record (EPR)
-
FOI/2022/0356 - Dog attacks and related injuries